Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : Barclays takes a positive view

share with twitter share with LinkedIn share with facebook
09/23/2020 | 03:31am EDT

Barclays's analyst Hassan Al-Wakeel has upgraded his rating from Neutral to Buy. The target price has been raised to EUR 55 from EUR 53.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
BARCLAYS PLC -0.41% 110.54 Delayed Quote.-38.48%
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.09% 68.7 Delayed Quote.4.15%
FRESENIUS SE & CO. KGAA -1.48% 33.86 Delayed Quote.-32.52%
share with twitter share with LinkedIn share with facebook
All news about FRESENIUS SE & CO. KGAA
04:44aFRESENIUS SE : Buy rating from JP Morgan
MD
04:25aFMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Goldman Sachs
MD
03:00aFMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg gives a Buy rating
MD
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
MD
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
MD
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
MD
10/21FRESENIUS : announces changes to Supervisory Board
PU
More news
Financials
Sales 2020 36 550 M 43 161 M 43 161 M
Net income 2020 1 826 M 2 156 M 2 156 M
Net Debt 2020 23 088 M 27 264 M 27 264 M
P/E ratio 2020 10,4x
Yield 2020 2,43%
Capitalization 18 876 M 22 307 M 22 290 M
EV / Sales 2020 1,15x
EV / Sales 2021 1,04x
Nbr of Employees 302 846
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 51,97 €
Last Close Price 33,86 €
Spread / Highest target 113%
Spread / Average Target 53,5%
Spread / Lowest Target -47,8%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-31.51%22 680
AIER EYE HOSPITAL GROUP CO., LTD.86.65%35 250
IHH HEALTHCARE-6.76%10 767
RAMSAY HEALTH CARE LIMITED-11.46%10 472
TOPCHOICE MEDICAL CORPORATION107.21%10 099
BANGKOK DUSIT MEDICAL SERVICES0.00%9 085